Herbalife's board approved a new $250 million share buyback on September 8, to be spread across the next three years, a vote of confidence in a stock trading in the single digits with a battered balance sheet. CFO John DeSimone framed the repurchase as a reflection of free cash flow generation and flexibility to keep investing in the business, and the second quarter, reported August 5, brought net sales of $1.3 billion, up 5.4% year over year and at the top of guidance, or 5.8% in constant currency, marking the fourth straight quarter of year-over-year sales expansion on both a reported and constant currency basis. Latin America led with net sales up 16.6%, while Asia Pacific rose 15.2%, or 23.1% at constant currency, and adjusted EBITDA of $166.6 million landed near the top of the guided range, beating guidance outright at $174.4 million in constant currency. The same quarter produced a net loss attributable to the company of $26.3 million, driven largely by a $94.6 million charge tied to extinguishing debt after an April refinancing, with gross margin slipping to 77.7% from 78.0% and adjusted EBITDA margin down 120 basis points to 12.6%, while China sales dropped 24.5% as reported and 29.0% at constant currency and EMEA fell 3.5%, or 5.6% adjusting for currency. Management narrowed full-year 2026 guidance, trimming the reported adjusted EBITDA range to $670 million to $690 million from a prior $675 million to $705 million on FX headwinds even as the constant currency outlook was raised, and DeSimone is set to retire at the end of 2026, handing the CFO role to Scott Schaefer on January 1, 2027, with the balance sheet still carrying a total shareholders' deficit of $466.9 million as of June 30 alongside more than $2 billion in long-term debt.
Herbalife Nutrition LtdBoard approved a new $250 million share buyback, a capital-return event for the battered stock.
